KiranRajVijMD

PubMed

• Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or...
  Cynthia X Ma, Vera J Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag, A Marilyn Leitch, Gary W Unzeitig, Jeremy Hoog, Aranzazu Fernandez-Martinez, Cheng Fan, Richard...> ;JAMA Oncology. 2024 Mar 1
• The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
  James R Cerhan, Matthew J Maurer, Brian K Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R C...> ;American Journal of Hematology. 2024 Mar 1
• 6 citations
  Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity.
  Xiuting Liu, Graham D Hogg, Chong Zuo, Nicholas C Borcherding, John M Baer, Varintra E Lander, Liang-I Kang, Brett L Knolhoff, Faiz Ahmad, Robin E Osterhout, Anna V Ga...> ;Cancer Cell. 2023 Jun 12
• 1 citations
  Idiopathic multicentric Castleman disease in an adolescent diagnosed following COVID-19 infection.
  Eman Mosleh, Sarah Mehta, Erika Young, Lily Zhang, Kiran Vij, Laura G Schuettpelz> ;Pediatric Blood & Cancer. 2023 Jun 1
• 1 citations
  Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus.
  Alejandro A Gru, Megan S Lim, Ahmet Dogan, Steven M Horwitz, Jan Delabie, Kai Fu, Deniz Peker, Vishnu V B Reddy, Mina L Xu, Kiran Vij, Graham W Slack, Roberto N Mirand...> ;Archives of Pathology & Laboratory Medicine. 2023 Jan 1
• 2 citations
  Phospho-Ser784-VCP Drives Resistance of Pancreatic Ductal Adenocarcinoma to Genotoxic Chemotherapies and Predicts the Chemo-Sensitizing Effect of VCP Inhibitor
  Faliang Wang, Kiran Vij, Lin Li, Paarth B. Dodhiawala, Kian-Huat Lim, Jieya Shao> ;Cancers. 2021 Oct 11
• 8 citations
  Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR.
  Sena Kim, Kidist Ashami, Sora Lim, Karl Staser, Kiran Vij, Srikanth Santhanam, Julie Ritchey, Sarah Peterson, Feng Gao, Matthew A. Ciorba, Matthew L. Cooper, John F. D...> ;Leukemia. 2021 Jul 24
• 16 citations
  Phospho-Ser784-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer
  Cuige Zhu, Anna Rogers, Karama Asleh, Jennifer R. Won, Dongxia Gao, Samuel Leung, Shan Li, Kiran Vij, Jian Zhu, Jason M. Held, Zhongsheng You, Torsten O. Nielsen, Jiey...> ;Cell Reports. 2020 Jun 9
• 5 citations
  Selective targeting of α4β1 integrin attenuates murine graft versus host disease.
  Bader Alahmari, Matthew L. Cooper, Kiran Vij, Julie Ritchey, Peter G. Ruminski, Feng Gao, Jaebok Choi, John F. DiPersio> ;Leukemia. 2020 Mar 9
• 9 citations
  Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis.
  Mina L. Xu, Ali Gabali, Eric D. Hsi, Yuri Fedoriw, Kiran Vij, Mohamed E. Salama, Radhakrishnan Ramchandren, Dennis P. O'Malley, Mark R. Wick, Maxime Battistella, Aleja...> ;The American Journal of Surgical Pathology. 2020 Feb 1
• 27 citations
  Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib
  Scott R. Goldsmith, S. Rehman, Cara Lunn Shirai, Kiran Vij, John F. DiPersio> ;Blood Advances. 2019 Dec 10
• Reactivity with the EpCAM-specific antibodies MOC-31 and Ber-Ep4 in plasma cell neoplasms: a potential diagnostic pitfall in cytology samples.
  R. Cody Weimholt, Nima Sharifai, Brooj Abro, Kiran Vij, Cory T. Bernadt> ;Journal of the American Society of Cytopathology. 2019 Apr 18
• 2 citations
  Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease‐negative first com...
  Joan How, Kiran Vij, Maryam Ebadi, Todd E. DeFor, Rizwan Romee, Michelle M Dolan, Celalettin Ustun, Daniel J. Weisdorf, Michael A. Linden, Armin Rashidi> ;American Journal of Hematology. 2018 Dec 1
• 58 citations
  Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease.
  Jaebok Choi, Matthew L. Cooper, Karl Staser, Kidist Ashami, Kiran Vij, Bing Wang, Lynne Marsala, Jessica Niswonger, Julie Ritchey, Bader Alahmari, Samuel Achilefu, Iku...> ;Leukemia. 2018 Apr 2
• 1 citations
  Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow.
  Dhruv Bansal, Kiran Vij, Gue Su Chang, Christopher A. Miller, John F. DiPersio, Ravi Vij, Sharon Heath, Peter Westervelt, John S. Welch, Todd A. Fehniger> ;Haematologica. 2018 Jun 1
• 50 citations
  Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvan...
  Nusayba Bagegni, Shana Thomas, Ning Liu, Jingqin Luo, Jeremy Hoog, Donald W. Northfelt, Matthew P. Goetz, Andres Forero, Matthias Bergqvist, Jakob Karen, Magnus Neumul...> ;Breast Cancer Research. 2017 Nov 21
• 52 citations
  A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer.
  Cynthia X. Ma, Vera J. Suman, Matthew P. Goetz, Donald W. Northfelt, Mark E. Burkard, Foluso O. Ademuyiwa, Michael Naughton, Julie A. Margenthaler, Rebecca Aft, Richar...> ;Clinical Cancer Research. 2017 Nov 15
• 13 citations
  HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice
  Alison K. Esser, Daniel Rauch, Jingyu Xiang, John C. S. Harding, Nicole A. Kohart, Michael H. Ross, Xinming Su, Kevin Wu, Devra Huey, Yalin Xu, Kiran Vij, Patrick L. G...> ;Oncotarget. 2017 Aug 27
• 213 citations
  NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.
  Cynthia X. Ma, Feng Gao, Jingqin Luo, Donald W. Northfelt, Matthew P. Goetz, Andres Forero, Jeremy Hoog, Michael Naughton, Foluso O. Ademuyiwa, Rama Suresh, Karen S. A...> ;Clinical Cancer Research. 2017 Aug 1
• Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state
  Armin Rashidi, Alaa M. Ali, Kiran Vij, Ryan Shanley, Rizwan Romee, Sarah Cooley, Peter Westervelt, John F. DiPersio, Jeffrey S. Miller, Daniel J. Weisdorf, Celalettin ...> ;American Journal of Hematology. 2017 Jul 19
• 27 citations
  Azacitidine Mitigates Graft-versus-Host Disease via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells In Vivo
  Matthew L. Cooper, Jaebok Choi, Darja Karpova, Kiran Vij, Julie Ritchey, Mark A. Schroeder, John F. DiPersio> ;Journal of Immunology. 2017 Mar 22
• 2 citations
  Tissue polymerase chain reaction for the diagnosis of cytomegalovirus disease after allogeneic hematopoietic cell transplantation.
  Armin Rashidi, Kiran Vij, Richard S. Buller, Kristine M. Wylie, Gregory A. Storch, John F. DiPersio> ;American Journal of Hematology. 2017 Feb 1
• 4 citations
  Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome.
  Eric J. Duncavage, J O'Brien, Kiran Vij, Christopher A. Miller, Gue Su Chang, Jin J Shao, Meagan A. Jacoby, Sharon Heath, Megan Janke, Kevin Elliott, Robert S. Fulton,...> ;Leukemia. 2016 Aug 30
• 5 citations
  Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
  Kiran Vij, Hanlin L. Wang> ;International Journal of Surgical Pathology. 2008 Apr 1
• 97 citations
  Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct role of Ret in spermatogenesis.
  Sanjay Jain, Cathy K. Naughton, Mao Yang, Amy Strickland, Kiran Vij, Mario Encinas, Judy P. Golden, Akshay Gupta, Robert O. Heuckeroth, Eugene M. Johnson, Jeffrey Milb...> ;Development. 2004 Nov 1
• Join now to see all